Summary
Johnson & Johnson (JNJ) filed an 8-K on July 18, 2022, to report its second-quarter financial results for the period ended July 3, 2022. The filing includes a press release detailing the company's sales and earnings performance for the quarter. Investors can find specific sales figures and earnings per share within the accompanying press release and supplementary sales data, which are attached as exhibits to this report. These documents provide insight into the company's operational performance and financial condition during the second quarter of 2022. While the 8-K itself is a notification of the release of these results, the attached exhibits are crucial for understanding the actual financial figures. Investors should refer to the press release (Exhibit 99.1) and the unaudited comparative supplementary sales data and condensed consolidated statement of earnings (Exhibit 99.2) for a comprehensive overview of JNJ's Q2 2022 performance, including key metrics such as revenue, net earnings, and earnings per share, broken down by segment and geographic region if provided.
Key Highlights
- 1Johnson & Johnson announced its second-quarter 2022 financial results on July 19, 2022, via an 8-K filing.
- 2The filing provides sales and earnings information for the quarter ended July 3, 2022.
- 3Key financial details are available in the attached press release (Exhibit 99.1).
- 4Unaudited comparative supplementary sales data and condensed consolidated statements of earnings are included as Exhibit 99.2.
- 5Investors can analyze the company's revenue and profit performance for the specified period.
- 6The report serves as an official notification of the release of JNJ's Q2 2022 financial performance.
- 7The Inline XBRL formatted cover page is included as Exhibit 104 for data accessibility.